Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07646197 · ClinicalTrials.gov registry record · NA
Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
A NA study, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT07646197 is a NA study that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 125 participants.
The verdict
NCT07646197, a NA study, is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The aim of this randomized interventional trial is to understand the effects of peanut consumption on patients with metabolic associated fatty liver. The main goal is to investigate if patients who consume peanuts have improved liver marker tests as well as metabolic profile. We will also investigate how peanuts alter the gut microbes and liver fat content in patients with metabolic associated fatty liver. * Participants will be randomized into intervention (peanut consumption for 12 weeks) and control (regular diet) arm. * Stool sample and blood (for biomarkers) collection across both arms at baseline and post-intervention * Daily log to be completed for tracking peanut consumption * 2-day Dietary recall at baseline, during Week 6 and Week 12 * Poat intervention Fibro scans for participants with baseline scans available
Interventions
- OTHER Peanut consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2026-06-09 |
| Est. Completion | 2028-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07646197
The ClinicalTrials.gov registry entry for NCT07646197 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut consumption is the first listed.
NCT07646197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07646197 about?
NCT07646197 is a clinical study titled "Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease". The aim of this randomized interventional trial is to understand the effects of peanut consumption on patients with metabolic associated fatty liver. The main goal is to investigate if patients who consume peanuts have improved liver marker tests as well as metabolic profile. We will also investigat...
What is the current status of trial NCT07646197?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2026-06-09. Estimated completion is 2028-06-09.
What interventions are being tested in trial NCT07646197?
The interventions under investigation include: Peanut consumption (OTHER).
Who is sponsoring clinical trial NCT07646197?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.